In February 2023, the life of the Muizz family took a dramatic turn when their youngest son, Mirza Noah Muizz, was diagnosed with severe aplastic anaemia, a rare bone marrow disorder that impairs the body’s ability to produce essential blood cells. At just 19 months old, Noah exhibited symptoms initially mistaken for a viral infection, including persistent fever, unusual paleness, bruising, and red spots on his skin. Medical evaluation revealed that Noah’s bone marrow had essentially ceased functioning, leaving him vulnerable to infections and severe complications.

Severe aplastic anaemia is a critical condition that, without effective treatment, carries a high mortality rate among children. Standard first-line therapies often involve immunosuppressive drugs aimed at halting the immune system’s attack on the bone marrow. However, these treatments did not yield improvements for Noah. A subsequent step towards potential recovery was a bone marrow transplant, but no fully matched donor could be found among Noah’s immediate family or the broader donor registries searched both within Malaysia and internationally.

In December 2023, Noah was referred to Universiti Malaya Medical Centre (UMMC), where a specialized paediatric bone marrow transplant team led by Prof Dr Hany Ariffin introduced the family to an alternative treatment known as haploidentical stem cell transplantation. This procedure allows a half-matched donor—such as a parent or sibling—to provide stem cells, offering hope for patients lacking fully matched donors.

Noah’s eight-year-old brother, Mika Naufal, became his first donor in early 2024. However, despite the transplant, Noah’s body rejected the donor cells after four weeks. The medical team then proposed a salvage haploidentical transplant, a complex and less common approach, with Noah’s father, Muizz Aiman, volunteering as the second donor. This transplant succeeded, allowing Noah to leave the hospital after nearly three months, though his recovery remained challenging.

Following the transplant, Noah developed acute graft-versus-host disease (GVHD), in which the donor’s immune cells attacked his skin and intestines, leading to severe complications. Additionally, he contracted a cytomegalovirus (CMV) infection during the rebuilding of his immune system. Over nearly two years, Noah underwent continuous treatment, including frequent hospital visits and careful management of infections and GVHD symptoms.

Noah’s parents emphasize the long and arduous nature of recovery from bone marrow transplantation, highlighting that the process extends well beyond the procedure itself. Today, Noah is a thriving five-year-old who continues to recuperate with the ongoing support of his medical team, family, and community.

The Muizz family credits the comprehensive care provided by UMMC’s transplant specialists and the generosity of numerous blood donors for Noah’s survival and improved quality of life. While the hospital strives to increase treatment accessibility, the family notes that the cost of haploidentical stem cell transplantation remains prohibitive for many, underscoring the importance of charitable contributions and community assistance.

By sharing their experience, the Muizz family hopes to raise awareness about severe aplastic anaemia and the potential of haploidentical bone marrow transplantation in saving lives. They encourage broader support for affected children through blood donation, financial aid, and increased public understanding of this rare but life-threatening condition.